PARTNERS
NGN-PET is supported by over € 3.3 million funding from the Innovative Medicines Initiative 2 Joint Undertaking, under grant agreement No 116072. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA Companies. The project duration is 3 years.
Read moreWORKPACKAGES
The ambition of the project is to provide a firm platform for the identification of effective NP targets and indicators and for drug screening, to bridge the gap between research and its application in the discovery of effective drugs. For this purpose, the NGN-PET project is organised in six work packages (WPs)
Read moreNEWS
NGN-PET project dissemination activities will primarily entail scientific interactions. A multi-level publication strategy will focus on publishing high impact articles of broad interest in leading international journals, as well as publishing more topic specific articles in specialized journals
Read more